Blumenschein, G., Devarakonda, S., Johnson, M., Moreno, V., Gainor, J., Edelman, M., Heymach, J., Govindan, R., Bachier, C., Spéville, B. D. d., Frigault, M., Olszanski, A., Lam, V., Hyland, N., Navenot, J., Fayngerts, S., Bai, J., Norry, E., & Fracasso, P. (n.d.). 278 Phase I clinical trial evaluating the safety of ADP-A2M10 SPEAR T-cells in patients with MAGE-A10+ advanced non-small cell lung cancer. Journal for immunotherapy of cancer, 8, A303. http://access.bl.uk/ark:/81055/vdc_100144719463.0x000002